DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep): A Trial Assessing Feasibility and Acceptability of an Intervention for Depressed Mood, Insomnia, and Fatigue Symptoms in Latino Cancer Patients
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 21 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests DESCANSO/REST, a mental health program for Spanish-speaking Latino people with cancer who have depression, sleep problems, and tiredness. The program can be offered through telehealth, or health visits from a distance. Mental health providers can also take part.
The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depression, insomnia, and fatigue. Investigators will test a special mental health intervention called DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep). The intervention can be delivered through telehealth.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Patients: Have solid tumor cancer confirmed by a tissue test, at stage I, II, or III.
- Patients: Are getting chemotherapy, radiation, or immunotherapy, or finished this treatment within the past year.
- Patients: Are age 21 or older and live in the mainland U.S. or Puerto Rico.
- Patients: Identify as Latino/a or Hispanic, prefer Spanish, and speak Spanish well or very well.
- Patients: Have tiredness and sleep problems with scores of at least 3 on the study’s symptom survey.
- Providers: Are mental health providers who treat Latino people with cancer or cancer survivors.
- Providers: Have at least 3 years of experience providing emotional and social support services to people with cancer or cancer survivors.
- Providers: Can read Spanish.
Who can't join
- Patients: Have thinking or memory problems that the study team believes would prevent them from understanding consent or taking part.
- Patients: In the past 12 months, have had conditions linked to tiredness and poor sleep, including thyroid problems, sleep apnea (pauses in breathing during sleep), chronic obstructive pulmonary disease (a long-term lung disease), nerve and muscle disease, or alcohol or drug abuse.
- Patients: Are pregnant or breastfeeding.
- Patients: Have any yes answer on the study’s suicide risk survey.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Provider Eligibility Criteria: Participant eligibility will be determined by a self-report screener. Inclusion Criteria Self-Report Criteria * Mental health provider * Treats Latino cancer patients and/or survivors * Has at least 3 years of clinical experience providing psychosocial services to cancer patients and/or survivors * Able to read Spanish determined by the question: "Can you read in Spanish? Yes/No" Patient Eligibility Criteria: A patient cannot be considered eligible for this study unless ALL of the following conditions are met. Participant eligibility will be determined by an initial EMR review followed by a self-report screener. Inclusion Criteria EMR Criteria * Documentation of Disease o Pathologically confirmed solid tumor cancer (either most recent or new diagnosis) * Definition of Disease \[or Measurable Disease\] o Diagnosed with stages I, II, or III * Prior Treatment * Currently undergoing systemic therapy (chemotherapy, radiation therapy, and/or immunotherapy) or within the first year following completion of systemic therapy Self-Report Criteria * Age ≥ 21 years * Lives in mainland U.S. or Puerto Rico * Identifies as Latino/a or Hispanic * Reports Spanish as their preferred language * Speaks Spanish "Very well" or "Well" as determined by the question: "How well do you speak Spanish?" * Presence of fatigue and disturbed sleep determined by a score of ≥ 3 on the MD Anderson Symptom Inventory Exclusion Criteria EMR Criteria o In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation Self-Report Criteria * History of comorbidities within the last 12 months associated with fatigue and poor sleep, including hypothyroidism or abnormal thyroid function, sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, alcohol or drug abuse * Pregnant or lactating, women only * Presence of suicidal risk determined by any affirmative response on the Columbia-Suicide Severity Rating Scale
Study sites (7)
NJ
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) · Basking Ridge, NJ 07920Devika Jutagir, PhD · Study contact · 646-888-8361More trials in Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) · Middletown, NJ 07748Devika Jutagir, PhD · Study contact · 646-888-8361More trials in Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) · Montvale, NJ 07645Devika Jutagir, PhD · Study contact · 646-888-8361More trials in Montvale
NY
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) · Commack, NY 11725Devika Jutagir, PhD · Study contact · 646-888-8361More trials in Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) · Harrison, NY 10604Devika Jutagir, PhD · Study contact · 646-888-8361More trials in Harrison
- Memorial Sloan Kettering Cancer Center · New York, NY 10065Devika Jutagir, PhD · Study contact · 646-888-8361Devika Jutagir, PhD · Principal investigatorMore trials in New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites) · Rockville Centre, NY 11553Devika Jutagir, PhD · Study contact · 646-888-8361More trials in Rockville Centre